NDUFB4 Human

NADH Dehydrogenase 1 Beta Subcomplex 4 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Definition and Core Characteristics

NDUFB4 (NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4) is a 15 kDa mitochondrial protein encoded by the NDUFB4 gene located on chromosome 3 (3q13.33) . It serves as a non-catalytic accessory subunit of Complex I (NADH dehydrogenase), the largest enzyme in the mitochondrial electron transport chain (ETC) .

CharacteristicDetail
Gene LocationChromosome 3q13.33 (6,130 base pairs)
Protein StructureHydrophobic transmembrane domain (N-terminal) + hydrophilic domain (C-terminal)
Subcellular LocalizationMitochondrial inner membrane, peripheral arm of Complex I

Role in Mitochondrial Respiration

NDUFB4 is critical for Complex I assembly and respirasome formation (I₁III₂IV₁), a supercomplex containing Complex I, III, and IV . Ablation of NDUFB4 disrupts respirasome integrity, impairing electron transport and ATP production .

Key Functions

  • Electron Transfer: Facilitates electron transport from NADH to ubiquinone via interactions with other subunits (e.g., NDUFA9) .

  • Respirasome Stability: Mutations (e.g., N24A, R30A) reduce Complex I activity by 31–40% and shift metabolism toward glycolysis .

Tissue Expression and Localization

NDUFB4 is ubiquitously expressed, with elevated levels in energy-demanding tissues:

TissueExpression LevelSubcellular Localization
BrainHighMitochondria
LiverModerateMitochondria
Skeletal MuscleHighMitochondria
HeartHighMitochondria

Data sourced from Human Protein Atlas .

Disease Relevance

NDUFB4 is tentatively linked to mitochondrial disorders, though evidence remains limited:

  • Current Status: Amber-listed in diagnostic panels (moderate evidence) due to only two reported cases .

  • Pathogenic Potential: Mutations may impair Complex I function, leading to ATP deficiency and oxidative stress .

Experimental Tools for Analysis

Rabbit polyclonal antibodies (e.g., Proteintech 27931-1-AP) enable detection across multiple platforms:

ApplicationSampleDilutionValidation
Western Blot (WB)Mouse heart tissue1:200–1:1000Reactivity confirmed
ImmunohistochemistryHuman stomach cancer1:50–1:500Antigen retrieval required
IF/ICCHeLa cells1:50–1:500Mitochondrial staining

Environmental and Chemical Modulators

NDUFB4 expression is influenced by diverse chemical agents:

ChemicalEffectModel System
Bisphenol A↑ mRNA/protein levelsHuman, mouse
Glyphosate↓ Protein levelsMouse
Resveratrol↑ mRNA levelsMouse
Rotenone↑ mRNA levelsHuman

Compiled from CTD and RGD databases .

Research Findings: Metabolic Impact

Studies using CRISPR-edited cells reveal:

  • Respiratory Deficits: NDUFB4 ablation reduces basal OCR by 99%, shifting ATP production to glycolysis .

  • Mutation Effects: N24A/R30A mutants restore partial respiration but exhibit lower ATP-linked respiration (33% reduction vs. WT) .

ParameterB4-KO CellsWT RescueN24A/R30A Mutants
Basal OCR0.1 pmol/min1.2 pmol/min0.8 pmol/min
Maximal OCR0.2 pmol/min1.8 pmol/min1.1 pmol/min
Glycolytic ATP99%50%50%

Data adapted from Seahorse XF analyses .

Interaction Network

NDUFB4 interacts with Complex I subunits and components of the ETC:

PartnerInteraction TypeEvidence
NDUFA9PhysicalCo-localization
NDUFB3Co-expressionSTRING database
NDUFC2FunctionalDatabase annotations

Product Specs

Introduction
NADH Dehydrogenase 1 Beta Subcomplex 4 (NDUFB4) is a protein that is part of Complex I, the first enzyme complex in the mitochondrial electron transport chain. This complex is responsible for transferring electrons from NADH to ubiquinone. NDUFB4 itself does not have catalytic activity and is considered a structural subunit.
Description
This product consists of the human NDUFB4 protein, recombinantly produced in E. coli. It is a single polypeptide chain of 110 amino acids (including a 23 amino acid His-tag at the N-terminus for purification) with a molecular weight of 12.6 kDa. The protein is not glycosylated. It has been purified using proprietary chromatographic techniques.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
The NDUFB4 protein is supplied at a concentration of 1 mg/ml in a buffer containing 20mM Tris-HCl (pH 8.0), 0.4M Urea, and 10% glycerol.
Stability
For short-term storage (up to 4 weeks), the product can be stored at 4°C. For long-term storage, it is recommended to store the product frozen at -20°C. Adding a carrier protein such as HSA or BSA (0.1%) is advisable for long-term storage. Repeated freezing and thawing of the product should be avoided.
Purity
The purity of the NDUFB4 protein is greater than 90% as determined by SDS-PAGE analysis.
Synonyms
B15, CI-B15, Complex I-B15, NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4, NADH-ubiquinone oxidoreductase B15 subunit.
Source
E.Coli
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMSFPKYK PSSLRTLPET LDPAEYNISP ETRRAQAERL AIRAQLKREY LLQYNDPNRR GLIENPALLR WAYARTINVY PNFRPTPKNS.

Q&A

What is NDUFB4 and what is its role in mitochondrial function?

NDUFB4 is an accessory subunit of mitochondrial complex I (CI) that participates in the assembly and stability of respiratory supercomplexes, particularly the I₁III₂IV₁ respirasome. Unlike core subunits that contain the catalytic machinery for electron transfer, NDUFB4 serves a structural role, helping to stabilize interactions between complex I and other respiratory chain complexes. Specifically, NDUFB4 contains residues that interact with the subunit UQCRC1 from complex III, suggesting it is integral for respirasome integrity .

NDUFB4 is located in the P-D module (proximal membrane domain) of complex I's membrane arm. Research has shown that complete loss of NDUFB4 results in incomplete CI assembly along with decreased expression of subunits in the P-D-b subassembly and N-module . This indicates that beyond its role in supercomplex formation, NDUFB4 is also essential for the proper assembly and stability of complex I itself.

How does NDUFB4 contribute to respiratory supercomplex formation?

NDUFB4 contributes to respiratory supercomplex formation through specific protein-protein interactions. In-depth analyses of human respirasome crystal structure data (PDB: 5XTH) have demonstrated that specific residues on the N-terminus of NDUFB4, particularly Asn24 and Arg30, form salt-bridging interactions with residues in the highly conserved loop (Y257-T266) of subunit UQCRC1 from complex III .

These molecular interactions serve as critical contact points between complex I and complex III, facilitating the assembly of the I₁III₂IV₁ respirasome. When these interactions are disrupted through point mutations (such as N24A and R30A), respirasome formation is impaired even when complex I assembly itself remains relatively intact . This demonstrates that NDUFB4 functions as a molecular bridge between respiratory complexes, essential for the higher-order organization of the electron transport chain into supercomplexes.

How is NDUFB4 expression regulated in different tissues and disease states?

NDUFB4 expression appears to be tissue-specific and can be altered in disease states. In studies of diabetic kidney disease (DKD), NDUFB4 was among several complex I subunits examined for expression changes. While some subunits like NDUFS4 showed consistent downregulation in diabetic models and in the glomeruli of DKD patients, NDUFB4 did not show consistent downregulation patterns in these contexts .

This differential regulation suggests tissue-specific and disease-specific control of NDUFB4 expression. Understanding the transcriptional and post-transcriptional mechanisms that regulate NDUFB4 expression in different tissues remains an important area for further research. Investigators studying NDUFB4 should consider tissue-specific expression patterns when designing experiments and interpreting results related to this subunit's role in health and disease.

What are the most effective methods for studying NDUFB4 interactions with other respiratory complex subunits?

Several complementary approaches have proven effective for studying NDUFB4's interactions with other respiratory complex subunits:

  • Structural Analysis: Using cryo-electron microscopy and X-ray crystallography to resolve the structure of respiratory supercomplexes. The human respirasome crystal structure (PDB: 5XTH) has been valuable in identifying interactions between NDUFB4 and other subunits .

  • Proximity Labeling: This technique can identify proteins that are in close spatial proximity to NDUFB4 in living cells. Research has employed proximity labeling coupled with super-resolution imaging to identify interactions between mitochondrial proteins .

  • Site-Directed Mutagenesis: Creating specific mutations in NDUFB4, such as the N24A and R30A mutations, can help determine which residues are critical for interactions with other subunits. This approach has successfully demonstrated the importance of these residues in respirasome formation .

  • Blue-Native PAGE (BN-PAGE): This technique allows for the separation and analysis of intact protein complexes. Using different detergents (digitonin for supercomplexes, Triton X-100 for individual complexes) enables researchers to study both the integration of NDUFB4 into complex I and its role in supercomplex formation .

  • Immunoprecipitation and Crosslinking: These techniques can directly assess protein-protein interactions between NDUFB4 and other subunits.

Each method provides complementary information, and a multi-faceted approach yields the most comprehensive understanding of NDUFB4's interactions within the respiratory chain.

What genetic modification approaches are most suitable for studying NDUFB4 function?

Based on current research, several genetic modification approaches have proven effective for studying NDUFB4 function:

  • CRISPR/Cas9 Knockout Systems: Complete NDUFB4 knockout models (B4-KO) have been generated using CRISPR/Cas9 technology in cell lines such as HEK293T . This approach allows researchers to study the consequences of complete NDUFB4 loss.

  • Point Mutation Models: Instead of complete knockout, introducing specific point mutations (like N24A and R30A) allows for more nuanced analysis of structure-function relationships. This approach has been valuable in dissecting NDUFB4's role in supercomplex formation without completely disrupting complex I assembly .

  • Rescue Experiments: Re-expressing wild-type or mutant NDUFB4 in knockout cells has been used to confirm the specificity of observed phenotypes and to compare the functional consequences of various mutations .

  • Conditional/Tissue-Specific Expression Systems: For in vivo studies, conditional or tissue-specific expression systems can be valuable for understanding the role of NDUFB4 in specific tissues or developmental stages.

When designing genetic modification experiments for NDUFB4, researchers should consider:

  • The possibility that complete knockout may affect complex I assembly, complicating interpretation of results

  • The advantage of point mutations for studying specific functions

  • The importance of appropriate controls, including rescue experiments

  • The potential benefits of inducible systems to study acute versus chronic effects of NDUFB4 loss

What are the optimal techniques for assessing NDUFB4's impact on mitochondrial function?

Several complementary techniques have been employed to comprehensively assess NDUFB4's impact on mitochondrial function:

  • Seahorse XF Analysis: This technique measures cellular oxygen consumption rate (OCR) and extracellular acidification rate (ECAR), providing real-time assessment of mitochondrial respiration and glycolytic flux. This has been used to demonstrate that NDUFB4 mutations affect basal, leak, and maximal OCRs as well as ATP-linked respiration .

  • Complex-Specific Respiratory Measurements: Using substrate-specific approaches (such as pyruvate/malate for CI and succinate for CII) allows researchers to distinguish between complex I-dependent and complex II-dependent respiration, revealing shifts in the electron transport chain's operation following NDUFB4 manipulation .

  • Blue-Native PAGE with Activity Staining: This technique combines electrophoretic separation of respiratory complexes with activity staining to assess the functional integrity of complexes and supercomplexes.

  • Metabolomics Analysis: Steady-state metabolomics has revealed that NDUFB4 mutations can cause global decreases in citric acid cycle metabolites, affecting NADH-generating substrates . This approach provides insights into the broader metabolic consequences of NDUFB4 dysfunction.

  • Membrane Potential Measurements: Using fluorescent dyes sensitive to mitochondrial membrane potential can assess the functional consequences of NDUFB4 manipulation on the proton-motive force.

  • Superoxide and ROS Production Assays: These measurements can determine whether NDUFB4 dysfunction increases oxidative stress.

  • Mitochondrial Morphology and Dynamics: Super-resolution microscopy and transmission electron microscopy can assess changes in mitochondrial network organization and cristae structure.

Combining these approaches provides a comprehensive view of how NDUFB4 impacts mitochondrial bioenergetics and cellular metabolism.

What mutations in NDUFB4 have been identified and what are their functional consequences?

While the provided search results primarily focus on experimental mutations rather than clinical mutations in NDUFB4, they do provide valuable information on how specific mutations affect function:

  • N24A Mutation: This experimental mutation in the Asn24 residue of NDUFB4 impairs respirasome assembly. Asn24 appears to form important interactions with the UQCRC1 subunit of complex III, and mutating this residue disrupts these interactions .

  • R30A Mutation: Similarly, this experimental mutation in the Arg30 residue disrupts NDUFB4's interaction with complex III components, impairing respirasome formation .

The functional consequences of these mutations include:

  • Impaired respirasome (I₁III₂IV₁) assembly

  • Reduced mitochondrial respiratory flux

  • Decreased citric acid cycle metabolites

  • Reduced ATP-linked respiration (by approximately 33%)

  • Shift from complex I-dependent to complex II-dependent respiration

It's worth noting that complete loss of NDUFB4 (knockout) has more severe consequences, including incomplete complex I assembly and decreased expression of subunits in the P-D-b subassembly and N-module . This suggests that NDUFB4 has roles beyond respirasome formation, potentially in the assembly and stability of complex I itself.

For a comprehensive understanding of clinical mutations in NDUFB4, researchers should consult specialized databases of mitochondrial disease mutations and more recent literature.

How does NDUFB4 dysfunction compare to mutations in other complex I accessory subunits?

The search results provide information on several other complex I accessory subunits with identified mutations, allowing for comparative analysis:

SubunitLocationExample MutationsPrimary ContactsFunctional Impact
NDUFA2N-modulep.Lys45Thr, p.Glu57Ala, p.Asp50AsnNDUFS1Complex I deficiency, destabilized binding to NDUFS1
NDUFV3N-modulep.Arg26Gln, p.Lys56Asn, p.Gly103AspNDUFV1, NDUFV2Potential impact on mitochondrial transit peptide and splicing
NDUFS4Q-modulep.Trp114Arg, p.Asp119HisMultiple subunitsMay regulate cristae remodeling in diabetic kidney disease
NDUFB3ND5-modulep.Trp22ArgNDUFB9, NDUFAB1, NDUFB2, ND5Affects membrane arm assembly
NDUFB8ND5-modulep.Pro76Gln, p.Cys144Trp, p.Tyr62HisMultiple subunitsAffects membrane arm assembly
NDUFB4P-D moduleN24A, R30A (experimental)UQCRC1 (Complex III)Impaired respirasome formation, reduced respiratory flux

NDUFB4 appears unique among these subunits in its primary role in connecting complex I to complex III for respirasome formation. While mutations in many other accessory subunits primarily affect complex I assembly or stability, NDUFB4 mutations (specifically N24A and R30A) can selectively impair supercomplex formation while preserving complex I assembly .

This comparative analysis suggests that different accessory subunits serve distinct roles within complex I, affecting different aspects of its assembly, stability, or supramolecular organization. Understanding these specific roles is crucial for interpreting the consequences of mutations in these subunits and their potential clinical manifestations.

What disease associations have been identified for NDUFB4 mutations?

  • Metabolic Implications: Experimental mutations in NDUFB4 (N24A and R30A) led to impaired respirasome formation, reduced mitochondrial respiratory flux, and a global decrease in citric acid cycle metabolites . These metabolic disturbances could potentially contribute to various diseases if they occurred in humans.

  • Potential Role in Mitochondrial Disease: As an accessory subunit of complex I, NDUFB4 dysfunction could potentially contribute to mitochondrial diseases, which typically manifest with neurological, muscular, and metabolic symptoms.

  • Cancer Context: While not directly linked to NDUFB4, the search results mention a screen of breast cancer patients that identified mutations in another complex I subunit (NDUFA2) , suggesting that researchers have investigated complex I subunit mutations in cancer contexts.

For comprehensive information on disease associations of NDUFB4 mutations, researchers should consult specialized databases of mitochondrial disease mutations and more recent literature. The lack of specific disease associations in the provided materials may indicate either limited research in this area or that such associations have not yet been firmly established.

How does NDUFB4 contribute to the dynamic assembly and disassembly of respiratory supercomplexes?

The dynamic assembly and disassembly of respiratory supercomplexes represents an adaptive mechanism for cells to respond to changing metabolic demands. NDUFB4 appears to play a crucial role in this process:

  • Structural Interface: NDUFB4 provides a critical structural interface between complex I and complex III through specific residues (particularly Asn24 and Arg30) that interact with the UQCRC1 subunit of complex III . These interactions help stabilize the respirasome (I₁III₂IV₁) structure.

  • Scaffold Function: Evidence from in vitro studies indicates that subassemblies of the P-D-a module may act as a scaffold to initiate conglomeration with complex III and complex IV to form respiratory supercomplexes . As part of this module, NDUFB4 likely contributes to this scaffolding function.

  • Regulation Potential: The fact that point mutations in NDUFB4 can selectively impair supercomplex formation without completely disrupting complex I suggests that modifications to NDUFB4 (potentially through post-translational modifications) could serve as a regulatory mechanism for controlling supercomplex assembly in response to metabolic cues.

Advanced research questions in this area include:

  • What post-translational modifications of NDUFB4 occur in response to different metabolic states?

  • How do these modifications affect its interaction with complex III components?

  • What signaling pathways regulate NDUFB4's role in supercomplex formation?

  • How does the stoichiometry of NDUFB4 relative to other subunits affect the dynamics of supercomplex assembly?

Addressing these questions will require combining structural biology approaches with dynamic cellular assays under different metabolic conditions.

What is the relationship between NDUFB4 and mitochondrial cristae remodeling?

While the search results don't directly address NDUFB4's role in cristae remodeling, they provide some contextual information that suggests potential relationships:

  • Supercomplex Organization and Cristae: Respiratory supercomplexes are known to be organized along cristae membranes, and their organization can influence cristae structure. Given NDUFB4's role in respirasome formation , it may indirectly influence cristae organization.

  • NDUFS4 and Cristae Remodeling: The search results indicate that another complex I subunit, NDUFS4, regulates cristae remodeling in diabetic kidney disease . This suggests a broader relationship between complex I components and cristae structure.

  • Potential Interactions with Cristae Shaping Proteins: The search results mention that proximity labeling with super-resolution imaging identified the cristae shaping protein STOML2 as linking NDUFS4 with improved cristae morphology . Similar approaches could be used to investigate whether NDUFB4 interacts with cristae shaping proteins.

Advanced research in this area might explore:

  • Whether NDUFB4-dependent respirasome formation influences cristae morphology

  • If NDUFB4 directly interacts with cristae shaping proteins like STOML2, OPA1, or Mic60

  • How disruption of NDUFB4 affects cristae ultrastructure in different cell types

  • Whether the effects of NDUFB4 on cellular bioenergetics are mediated partly through cristae remodeling

Such research would benefit from combining super-resolution microscopy, electron microscopy, proximity labeling, and functional assays to establish causal relationships between NDUFB4, respirasome formation, and cristae structure.

How do post-translational modifications of NDUFB4 influence its function in different physiological contexts?

Potential post-translational modifications that might regulate NDUFB4 include:

  • Phosphorylation: Phosphorylation of complex I subunits has been reported in various contexts and can affect complex I activity. Phosphorylation of NDUFB4, particularly near its interaction sites with complex III components, could potentially regulate respirasome assembly.

  • Acetylation: Mitochondrial proteins are frequently regulated by acetylation, which responds to metabolic status through the activity of sirtuins and other deacetylases.

  • Oxidative Modifications: Given NDUFB4's location in the electron transport chain, it may be susceptible to oxidative modifications that could affect its function, particularly under conditions of oxidative stress.

Advanced research questions in this area include:

  • What specific PTMs occur on NDUFB4 under different physiological and pathological conditions?

  • How do these PTMs affect NDUFB4's interaction with complex III components?

  • What enzymes regulate NDUFB4 PTMs, and how are they themselves regulated by cellular signaling pathways?

  • Can manipulation of NDUFB4 PTMs alter respirasome formation and cellular bioenergetics?

Addressing these questions would require mass spectrometry-based proteomic approaches, site-directed mutagenesis of putative modification sites, and functional assays under different physiological conditions.

What are the most effective experimental designs for studying NDUFB4's role in bioenergetics under different metabolic conditions?

Based on the search results and current research approaches, effective experimental designs for studying NDUFB4's role in bioenergetics include:

  • Genetic Manipulation Coupled with Metabolic Stress:

    • Generate cell lines with wild-type NDUFB4, NDUFB4 knockout, and NDUFB4 point mutations (N24A, R30A)

    • Subject these cell lines to different metabolic conditions (glucose limitation, fatty acid supplementation, hypoxia)

    • Measure respiration, ATP production, and metabolite profiles under each condition

  • Inducible Expression Systems:

    • Create cell lines with inducible NDUFB4 expression or inducible dominant-negative NDUFB4 variants

    • Manipulate NDUFB4 function at specific time points relative to metabolic challenges

    • This approach allows for studying acute versus chronic effects of NDUFB4 dysfunction

  • Substrate-Specific Respiratory Analysis:

    • Use Seahorse XF analysis with different substrate combinations to assess complex I-specific versus complex II-specific respiration

    • This approach has already revealed shifts from CI- to CII-linked respiration following NDUFB4 mutation

  • Metabolic Flux Analysis:

    • Use isotope-labeled metabolites (e.g., 13C-glucose, 13C-glutamine) to trace metabolic flux through different pathways

    • Compare flux distributions between cells with normal versus disrupted NDUFB4 function

  • Combined Structural and Functional Analysis:

    • Correlate respirasome assembly state (assessed by BN-PAGE) with functional outcomes under different metabolic conditions

    • This approach can help establish causal relationships between structural changes and functional consequences

These experimental designs should be tailored to address specific research questions about NDUFB4's role in adapting mitochondrial function to different metabolic demands.

How can researchers effectively model NDUFB4 dysfunction in vivo?

While the search results primarily describe cellular models of NDUFB4 dysfunction, researchers interested in in vivo models might consider the following approaches:

  • Conditional Knockout Mouse Models:

    • Generate mice with floxed NDUFB4 alleles that can be deleted in specific tissues using appropriate Cre recombinase lines

    • This approach allows for studying tissue-specific effects of NDUFB4 loss while avoiding embryonic lethality if complete knockout is lethal

  • Knock-in Mouse Models with Specific Mutations:

    • Create mice harboring specific NDUFB4 mutations (such as N24A or R30A) to study respirasome dysfunction without complete complex I disruption

    • This approach parallels the successful cell models described in the search results

  • Transgenic Overexpression Models:

    • Similar to the podocyte-specific NDUFS4 transgenic mice described in the search results , create tissue-specific NDUFB4 overexpression models

    • This approach can help understand whether NDUFB4 overexpression is protective in disease models

  • Zebrafish Models:

    • Zebrafish offer advantages for studying mitochondrial dysfunction, including optical transparency for imaging and ease of genetic manipulation

    • CRISPR/Cas9 can be used to generate NDUFB4 mutant zebrafish

  • Disease Challenge Studies:

    • Subject NDUFB4 mutant animals to relevant disease challenges (metabolic stress, oxidative stress, inflammation)

    • This can reveal how NDUFB4 dysfunction affects susceptibility to and progression of various pathologies

When designing in vivo models, researchers should carefully consider:

  • Potential developmental effects of NDUFB4 dysfunction

  • Tissue-specific expression patterns of NDUFB4

  • Appropriate controls, including rescue experiments

  • Relevant physiological and pathological readouts

What approaches can resolve contradictory findings about NDUFB4 function across different experimental systems?

When faced with contradictory findings about NDUFB4 function across different experimental systems, researchers can employ several approaches to resolve these discrepancies:

  • Standardized Experimental Conditions:

    • Establish standardized protocols for cell culture conditions, including medium composition, oxygen tension, and passage number

    • Directly compare different cell types under identical conditions

    • This minimizes variability due to experimental conditions rather than true biological differences

  • Multi-System Validation:

    • Test key findings across multiple complementary systems (different cell lines, primary cells, animal models)

    • Findings that replicate across systems are more likely to represent fundamental aspects of NDUFB4 function

  • Genetic Background Considerations:

    • Assess the role of genetic background in determining NDUFB4 function

    • For cellular systems, isogenic cell lines with defined NDUFB4 manipulations can minimize confounding variables

  • Comprehensive Phenotyping:

    • Apply multiple complementary assays to assess NDUFB4 function

    • This includes structural assessments (BN-PAGE, proximity labeling), functional measurements (respiration, ATP production), and downstream consequences (metabolomics)

    • Comprehensive phenotyping can reveal whether apparent contradictions reflect different aspects of NDUFB4 function

  • Context-Dependent Function Analysis:

    • Systematically vary experimental conditions (nutrient availability, oxygen levels, energy demand) to test whether NDUFB4 function is context-dependent

    • This can reveal whether contradictory findings reflect true biological plasticity in NDUFB4 function

  • Temporal Dynamics:

    • Investigate acute versus chronic effects of NDUFB4 manipulation

    • Contradictory findings may reflect different temporal phases of the cellular response to NDUFB4 dysfunction

By systematically addressing these factors, researchers can distinguish between true biological variations in NDUFB4 function and technical artifacts or context-dependent effects.

What are the most pressing unanswered questions about NDUFB4 function?

Based on the current state of knowledge reflected in the search results, several pressing questions about NDUFB4 remain unanswered:

  • Clinical Relevance: Are there human diseases associated with NDUFB4 mutations, and what are their clinical manifestations? The search results do not describe specific NDUFB4 mutations in patients, representing a significant knowledge gap.

  • Regulatory Mechanisms: How is NDUFB4 expression and function regulated in different tissues and under different physiological conditions? Understanding these regulatory mechanisms could provide insights into how cells adapt their respiratory chain organization.

  • Post-Translational Modifications: What post-translational modifications affect NDUFB4, and how do they influence its function in supercomplex assembly? This represents an unexplored area of potential regulation.

  • Tissue-Specific Functions: Does NDUFB4 have different roles or importance in different tissues? The search results suggest tissue-specific expression patterns , but the functional implications remain unclear.

  • Interaction with Metabolic Pathways: How does NDUFB4-dependent respirasome formation influence or respond to changes in different metabolic pathways? While the search results indicate metabolic consequences of NDUFB4 dysfunction , the bidirectional relationship requires further exploration.

  • Therapeutic Potential: Could targeting NDUFB4 or its interactions provide therapeutic benefits in mitochondrial diseases or other conditions? This translational aspect remains largely unexplored.

Addressing these questions will require integrating structural biology, genetics, biochemistry, and systems biology approaches.

What emerging technologies will advance our understanding of NDUFB4 biology?

Several emerging technologies promise to significantly advance our understanding of NDUFB4 biology:

  • Cryo-Electron Tomography: This technique allows visualization of macromolecular complexes in their native cellular environment. Applied to mitochondria, it could reveal how NDUFB4 contributes to supercomplex organization within the native cristae membrane.

  • Single-Cell Omics: Single-cell transcriptomics, proteomics, and metabolomics can reveal cell-to-cell variability in NDUFB4 expression and function, potentially uncovering previously unrecognized heterogeneity in mitochondrial organization.

  • Advanced Proximity Labeling: Techniques like TurboID and APEX2 can identify proteins in close proximity to NDUFB4 with high temporal resolution, helping to map its dynamic interactome under different conditions.

  • Live-Cell Super-Resolution Microscopy: These techniques can visualize respiratory complex organization in living cells, potentially revealing dynamic aspects of NDUFB4-dependent supercomplex assembly and disassembly.

  • Mitochondria-Targeted CRISPR Screening: This approach can identify genetic modifiers of NDUFB4 function, revealing previously unknown regulatory pathways.

  • Organoid Models: Three-dimensional organoid cultures can provide more physiologically relevant models for studying NDUFB4 function in different tissue contexts.

  • Computational Modeling: Integrating structural data with molecular dynamics simulations can predict how mutations or post-translational modifications affect NDUFB4 interactions with other proteins.

These technologies, especially when used in combination, have the potential to transform our understanding of NDUFB4's role in mitochondrial function and cellular bioenergetics.

How might understanding NDUFB4 function contribute to therapeutic approaches for mitochondrial diseases?

While the search results don't directly address therapeutic applications related to NDUFB4, we can extrapolate potential contributions based on current knowledge:

  • Targeted Supercomplex Stabilization: Understanding how NDUFB4 contributes to respirasome formation could inform the development of small molecules that stabilize these supercomplexes in diseases where they are disrupted. The identified interaction points between NDUFB4 and complex III components provide potential targets for such interventions.

  • Biomarkers for Mitochondrial Dysfunction: Changes in NDUFB4 expression, modification, or interactions could serve as biomarkers for specific forms of mitochondrial dysfunction, potentially improving diagnosis or monitoring of mitochondrial diseases.

  • Gene Therapy Approaches: For conditions involving NDUFB4 mutations, gene therapy to restore wild-type NDUFB4 could potentially restore respirasome formation and mitochondrial function. The rescue experiments described in the search results provide proof-of-concept for this approach.

  • Metabolic Bypass Strategies: The finding that NDUFB4 dysfunction leads to a shift from complex I-dependent to complex II-dependent respiration suggests that therapeutic approaches might target this metabolic adaptation, either enhancing it as a compensatory mechanism or addressing its downstream consequences.

  • Cristae Remodeling Targets: If NDUFB4 affects cristae structure, as suggested by the relationship between other complex I components and cristae remodeling , therapies targeting cristae architecture might be effective in conditions involving NDUFB4 dysfunction.

Product Science Overview

Structure and Function

NDUFB4 is an accessory subunit of Complex I, which is the first enzyme complex in the mitochondrial electron transport chain. Complex I is responsible for transferring electrons from NADH to ubiquinone, a process that is essential for ATP synthesis through oxidative phosphorylation . Although NDUFB4 is not directly involved in the catalytic activity of Complex I, it is believed to play a role in the structural stability and functional assembly of the complex .

Genetic Information

The NDUFB4 gene is located on chromosome 3 and encodes a protein that is approximately 15 kDa in size . The gene has several aliases, including NADH:Ubiquinone Oxidoreductase Subunit B4, Complex I-B15, and CI-B15 . The protein is expressed in various tissues and is essential for normal mitochondrial function .

Clinical Significance

Mutations or dysfunctions in the NDUFB4 gene can lead to mitochondrial diseases and other disorders. For example, it has been associated with Hantavirus Hemorrhagic Fever with Renal Syndrome and other mitochondrial-related diseases . Understanding the role of NDUFB4 in these conditions can provide insights into potential therapeutic targets.

Recombinant NDUFB4

Recombinant human NDUFB4 protein is often used in research to study its function and role in the mitochondrial respiratory chain. It is typically expressed in Escherichia coli and purified to a high degree of purity (>90%) for use in various biochemical assays . The recombinant protein is useful for studying the structural and functional aspects of Complex I, as well as for developing potential therapeutic interventions .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.